
Preclinical Research Outsourcing Services: Global Markets
Description
Preclinical Research Outsourcing Services: Global Markets
Report Scope:
This report identifies the global preclinical research outsourcing services market, along with all major global preclinical CRO companies. The total preclinical research outsourcing services market is segmented globally and by geographic regions. The service areas provided by preclinical CROs are extensively covered as well. The report offers a detailed examination of preclinical services, analyzes market trends for preclinical research outsourcing services with data from 2020, estimates from 2021, and projections of CAGR through 2026 (forecast period 2021–2026).
This report provides a comprehensive analysis of the top preclinical CROs and evolving roles in the preclinical outsourcing services. CRO expertise within certain therapeutic areas and experience with new and adaptive study design protocols can reduce costs and study duration. CROs are expected to continue to play an increasing role in many aspects of the preclinical and clinical trial process.
Strong demand for CROs leads to heightened market assessments and many blockbuster mergers and acquisitions (M&As). M&A activity has led to a few companies to develop proficiency across many areas of the clinical trial process. However, niche players still play crucial roles. This report analyzes emerging trends and changing dynamics within the preclinical research outsourcing services industry.
Report Includes:
- 24 data tables and 12 additional tables
- An up-to-date review and analysis of the global markets for preclinical research outsourcing services
- Analyses of the global market trends, with historic revenue (sales) data from 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global market size for preclinical research outsourcing services, projected growth trends, and corresponding market share analysis by functional services and geographic region
- In-depth information (facts and figures) concerning market drivers, market deterrents and other macroeconomic forces affecting the current and future market demand
- Identification of companies best positioned to meet this demand owing to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
- Regulatory structure for preclinical research studies in the pharmaceuticals industry, marketed and pipeline products, pricing and reimbursement structure, and major developments influencing the progress of this market
- Detailed analysis on the strength, weakness, and opportunities of the prominent players operating in the global preclinical research outsourcing services market
- Insight into recent industry structure, current competitive scenario, increasing investments on R&D activities, current pharma/CRO contracts and company value share analysis based on their segmental revenues
- Company profiles of major players, including Eurofins Scientific, IQVIA, Labcorp, SGS SA, and Thermo Fisher
Report Scope:
This report identifies the global preclinical research outsourcing services market, along with all major global preclinical CRO companies. The total preclinical research outsourcing services market is segmented globally and by geographic regions. The service areas provided by preclinical CROs are extensively covered as well. The report offers a detailed examination of preclinical services, analyzes market trends for preclinical research outsourcing services with data from 2020, estimates from 2021, and projections of CAGR through 2026 (forecast period 2021–2026).
This report provides a comprehensive analysis of the top preclinical CROs and evolving roles in the preclinical outsourcing services. CRO expertise within certain therapeutic areas and experience with new and adaptive study design protocols can reduce costs and study duration. CROs are expected to continue to play an increasing role in many aspects of the preclinical and clinical trial process.
Strong demand for CROs leads to heightened market assessments and many blockbuster mergers and acquisitions (M&As). M&A activity has led to a few companies to develop proficiency across many areas of the clinical trial process. However, niche players still play crucial roles. This report analyzes emerging trends and changing dynamics within the preclinical research outsourcing services industry.
Report Includes:
- 24 data tables and 12 additional tables
- An up-to-date review and analysis of the global markets for preclinical research outsourcing services
- Analyses of the global market trends, with historic revenue (sales) data from 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global market size for preclinical research outsourcing services, projected growth trends, and corresponding market share analysis by functional services and geographic region
- In-depth information (facts and figures) concerning market drivers, market deterrents and other macroeconomic forces affecting the current and future market demand
- Identification of companies best positioned to meet this demand owing to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
- Regulatory structure for preclinical research studies in the pharmaceuticals industry, marketed and pipeline products, pricing and reimbursement structure, and major developments influencing the progress of this market
- Detailed analysis on the strength, weakness, and opportunities of the prominent players operating in the global preclinical research outsourcing services market
- Insight into recent industry structure, current competitive scenario, increasing investments on R&D activities, current pharma/CRO contracts and company value share analysis based on their segmental revenues
- Company profiles of major players, including Eurofins Scientific, IQVIA, Labcorp, SGS SA, and Thermo Fisher
Table of Contents
147 Pages
- Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- BCC Custom Research
- Related BCC Research Reports
- Chapter 2 Summary and Highlights
- Chapter 3 Market Dynamics
- Market Drivers
- Rising R&D Investment
- Growth in Outsourcing of Non-Core Function
- CROs Add Efficiency
- Market Restraints
- Challenges in Preclinical Research Outsourcing
- Lack of Skilled Professionals
- Market Opportunities
- Growing Opportunities in Asia-Pacific
- Inorganic Strategies
- Emerging Markets
- Chapter 4 Impact of COVID-19
- Overview of COVID-19 Crisis
- Impact of COVID-19 on the CRO Market
- Current Outlook
- Chapter 5 Global Market Overview
- Preclinical Process Overview
- Market for Drug Substance/Active Pharmaceutical Ingredient Manufacturing for Drug Development
- Manufacturers
- Market Estimate for Outsourcing API Manufacturing for Drug Development
- Formulation and Dosage Design Outsourcing Services
- Companies
- Market Overview and Estimates for Outsourcing of Formulation Development
- Analytical/Bioanalytical Methods Development, Validation and Testing
- Analytical Methods Development
- Analytical Methods Validation, Verification and Qualification
- Analytical Testing Method Development and Validation Market Landscape and Estimates
- Companies/Providers
- Metabolism, Pharmacokinetics and Toxicology Outsourcing
- Companies/Providers
- Market Estimates: Metabolism, Pharmacokinetics and Toxicology Outsourcing Services
- Preclinical Stage Outsourcing Services
- CROs and Preclinical Research Outsourcing
- Contract Manufacturing
- Contract Research
- Chapter 6 Regulatory Landscape
- FDA Regulation and Impact
- Regulations on Sponsor Activities
- The Declaration of Helsinki
- CDISC Standards
- Regulations for Contract Manufacturing Services
- Regulations for Contract Pharmaceutical Clinical Research in Each Stage of Drug Discovery and Development Process
- Current Market Trends
- Existing Drugs for New Indications
- Increased Competition
- Chapter 7 Market Analysis by Functional Service
- Discovery Services
- Chemistry
- Bioanalysis
- Toxicology
- Chapter 8 Market Analysis by Region
- Overview
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- South America
- Middle East & Africa
- Chapter 9 Competitive Landscape
- Market Share Analysis
- Current Pharma/CRO Contracts
- Mergers and Acquisitions
- Chapter 10 Analysis of Market Opportunities
- Porter's Five Forces Analysis
- Threat of New Entrants
- Threat of Substitutes
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Competitive Rivalry/Degree of Competition
- SWOT Analysis
- Strengths of the Global Market for Preclinical Research Outsourcing Services
- Challenges within the Global Market for Preclinical Research Outsourcing Services
- Opportunities in the Global Market for Preclinical Research Outsourcing Services
- Threats to the Global Market for Preclinical Research Outsourcing Services
- Chapter 11 Company Profiles
- Top 11 CROs
- CHARLES RIVER LABORATORIES
- EUROFINS SCIENTIFIC
- EVOTEC
- FRONTAGE LABS
- ICON PLC
- IQVIA
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- MEDPACE
- SGS SA
- THERMO FISHER SCIENTIFIC INC.
- WUXI APPTEC
- Chapter 12 Appendix: Abbreviations and Acronyms
- List of Tables
- Summary Table : Global Market for Preclinical Research Outsourcing Services, by Preclinical Services, Through 2026
- Table 1 : R&D Investment, by Major Companies, 2019-2020
- Table 2 : Leading CROs in India
- Table 3 : Companies in the API Manufacturing Sector/Average Annual Revenues
- Table 4 : Companies Providing Formulation and Dosage Design Services for Drug Development (Examples)
- Table 5 : Distribution of Company Shares of the CDMO Sector by Revenue Range
- Table 6 : Companies Providing Analytical Testing Method Development and Validation Services for Drug Development (Examples)
- Table 7 : Companies Providing Drug Metabolism and Toxicology Services for Preclinical Drug Development (Examples)
- Table 8 : New Drug Approvals in the Global Biopharmaceuticals Market, 2006-2021
- Table 9 : Approved Drugs Repurposed for Infectious Diseases
- Table 10 : Global Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
- Table 11 : Global Market for Discovery Services, by Region, Through 2026
- Table 12 : Global Market for Chemistry Services, by Region, Through 2026
- Table 13 : Global Market for Bioanalysis Services, by Region, Through 2026
- Table 14 : Global Market for Toxicology Services, by Region, Through 2026
- Table 15 : Global Market for Preclinical Research Outsourcing Services, by Region, Through 2026
- Table 16 : North American Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
- Table 17 : European Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
- Table 18 : Asia-Pacific Clinical Trial Regulatory Bodies
- Table 19 : Asia-Pacific Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
- Table 20 : RoW Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
- Table 21 : Pharma and CRO Partnership Alliances for Preclinical Research Services
- Table 22 : Recent M&As in CROs and Pharma Outsourcing Sector, 2016-2021
- Table 23 : Porter’s Five Forces Analysis
- Table 24 : Service Offerings, Major CROs
- Table 25 : Charles River Laboratories: Revenues, 2018-2020
- Table 26 : Eurofins Scientific: Revenue, 2018-2020
- Table 27 : Evotec: Revenues, 2018-2020
- Table 28 : Frontage Labs: Revenue, 2018-2020
- Table 29 : ICON plc: Revenue, 2018-2020
- Table 30 : IQVIA: Revenues, 2018-2020
- Table 31 : LabCorp: Revenue, 2018-2020
- Table 32 : Medpace: Revenues, 2018-2020
- Table 33 : SGS SA: Revenue, 2018-2020
- Table 34 : Thermo Fisher Scientific Inc.: Revenue, 2018-2020
- Table 35 : WuXi AppTec: Revenue, 2018-2020
- Table 36 : Abbreviations and Acronyms
- List of Figures
- Summary Figure : Global Market for Preclinical Research Outsourcing Services, by Preclinical Services, 2020–2026
- Figure 1 : Drug Approval Timeline
- Figure 2 : FDA cGMP Manufacturing Guidance Documents
- Figure 3 : FDA Site Inspections
- Figure 4 : European cGMP Guideline Documentation
- Figure 5 : European Site Inspection Outcomes
- Figure 6 : Global Market Size and Growth of Preclinical Research Outsourcing Services, 2019-2026
- Figure 7 : Pharma R&D Spending, 2016-2026
- Figure 8 : Global Prescription Drug Sales, 2016-2026
- Figure 9 : Global Market Shares of Preclinical Research Outsourcing Services, by Functional Service, 2020
- Figure 10 : Global Market for Discovery Services, 2019-2026
- Figure 11 : Global Market for Discovery Services, by Region, 2019-2026
- Figure 12 : Global Market for Chemistry Services, 2019-2026
- Figure 13 : Global Market for Bioanalysis Services, 2019-2026
- Figure 14 : Global Market for Bioanalysis Services, by Region, 2019-2026
- Figure 15 : Global Market for Toxicology Services, 2019-2026
- Figure 16 : Global Market for Toxicology Services, by Region, 2019-2026
- Figure 17 : Global Market for Preclinical Research Outsourcing Services, by Region, 2020–2026
- Figure 18 : Global Market Shares of Preclinical Research Outsourcing Services, by Region, 2020
- Figure 19 : North American Market for Preclinical Research Outsourcing Services, 2020–2026
- Figure 20 : European Market for Preclinical Research Outsourcing Services, 2020–2026
- Figure 21 : Asia-Pacific Market for Preclinical Research Outsourcing Services, 2020–2026
- Figure 22 : Asia-Pacific Market for Preclinical Research Outsourcing Services, 2020–2026
- Figure 23 : Global Market Shares of Leading Preclinical Research Outsourcing Service Providers, 2020
- Figure 24 : Expanding Value, Outsourcing Deals Involving CROs, 2007-2017
- Figure 25 : SWOT Analysis of the DTC Testing Market
- Figure 26 : Charles River Laboratories: Revenue Share, by Segment, 2020
- Figure 27 : Eurofins Scientific: Revenue Share, by Segment, 2020
- Figure 28 : Evotec: Revenue Share, by Segment, 2020
- Figure 29 : Frontage Labs: Revenue Share, by Segment, 2020
- Figure 30 : IQVIA: Revenue Share, by Segment, 2020
- Figure 31 : LabCorp: Revenue Share, by Segment, 2020
- Figure 32 : SGS SA: Revenue Share, by Segment, 2020
- Figure 33 : Thermo Fisher Scientific Inc.: Revenue Share, by Segment, 2020
- Figure 34 : WuXi AppTec: Revenue Share, by Segment, 2020
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.